Bioactive silica-calcium phosphate nanocomposite (SCPC) has been coated on Ti-6Al-4V implant employing an electrophoretic deposition (EPD) technique. The effects of composition and pH of the suspending medium on the zeta potential of three different SCPC formulations; SCPC25, SCPC50 and SCPC75 were analyzed. The average zeta potential of SCPC50 in pure ethanol was more negative than that of SCPC25 or SCPC75; however, the difference was not statistically significant. Discs of Ti-6Al-4V were passivated, coated with SCPC50 (200 nm-10 μm) and thermally treated at 600-800°C to produce a coating thickness in the range of 43.1 ± 5.7 to 30.1 ± 4.6 μm. After treatment at 600, 700, and 800°C, the adhesion strength at the SCPC50/Ti-6Al-4V interface was 42.6 ± 3.6, 44.7 ± 8.7, and 47.2 ± 4.3 MPa, respectively. SEM-EDX analyses of SCPC50-coated Ti-6Al-4V preimmersed in PBS for 7 days showed the formation of a Ca-deficient hydroxyapatite surface layer. ICP-OES analyses of the immersing solution (n = 6) showed an increase in the ionic concentration of Si from 3.3 ± 0.9 to 5.0 ± 1.2 ppm between days 1 and 4; after which no significant change in the Si concentration was measured. Bone marrow mesenchymal stem cells attached to the SCPC50-coated implants expressed significantly higher (p < 0.05) alkaline phosphatase activity (82.4 ± 25.6 nmoles p-NP/mg protein/min) than that expressed by cells attached to HA-coated or uncoated implants. Results of the study suggest that bioactive SCPC50 can efficiently be coated on Ti-6Al-4V using EPD. The SCPC50 coating has the potential to enhance bone integration with the orthopedic implant.
No takes yet. Share an insight, caveat, or question.
Aniket et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Journal of Biomedical Materials Research Part B Applied Biomaterials